Treace Files Patent Suit Against Zimmer Biomet, Paragon 28

Treace Medical Concepts has filed a lawsuit against Zimmer Biomet and Paragon 28, claiming the infringement of four patents related to its Lapiplasty 3D Bunion Correction technologies.

The lawsuit was filed in the U.S. District Court for the District of Delaware. It seeks injunctive relief and damages.

Treace’s patent portfolio includes 80 granted U.S. patents, with a further 26 granted patents worldwide and more than 150 pending patent applications.

“Treace Medical was the first company to develop, patent, and introduce an instrumented 3D bunion correction system for true tri-planar lapidus bunion correction and is the recognized leader in the surgical treatment of bunions. We believe that this lawsuit is necessary to protect the significant investments we have made in our pioneering research and technology, which is in the best interest of our stockholders,” said John T. Treace, Chairman, CEO and Founder of Treace. “Enforcing and defending our intellectual property helps to drive our ability to continue to innovate solutions that benefit patients.”

In October, the company filed a lawsuit against Stryker and subsidiary Wright Medical, alleging infringement of nine patents related to Lapiplasty and unfair competition. The lawsuit was filed in the U.S. District Court for the District of New Jersey.